Annovis Bio, Inc. (ANVS)

Annovis Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.13	10.55	5.75	28.38	45.69	8.07
Cash & Short-Term Investments	17.13	10.55	5.75	28.38	45.69	8.07
Cash Growth	328.50%	83.36%	-79.72%	-37.89%	465.79%	434488.70%
Prepaid Expenses	0.47	0.37	0.04	0.1	0.07	0.04
Other Current Assets	3.85	3.01	4.41	7.54	0.24	0.01
Total Current Assets	21.45	13.93	10.21	36.02	46	8.12
Total Assets	21.45	13.93	10.21	36.02	46	8.12
Accounts Payable	0.97	2.31	1.29	3.96	0.69	0.34
Accrued Expenses	1.83	1.58	2.99	3.74	0.82	0.24
Total Current Liabilities	2.81	3.88	4.28	7.7	1.51	0.58
Other Long-Term Liabilities	0.32	0.74	13.68	-	-	-
Total Liabilities	3.12	4.62	17.96	7.7	1.51	0.58
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	164.94	144.16	102.51	82.38	73.22	21.78
Retained Earnings	-146.61	-134.85	-110.26	-54.05	-28.73	-14.24
Total Common Equity	18.33	9.31	-7.75	28.32	44.49	7.54
Shareholders' Equity	18.33	9.31	-7.75	28.32	44.49	7.54
Total Liabilities & Equity	21.45	13.93	10.21	36.02	46	8.12
Net Cash (Debt)	17.13	10.55	5.75	28.38	45.69	8.07
Net Cash Growth	328.50%	83.36%	-79.72%	-37.89%	465.79%	-
Net Cash Per Share	1.08	0.86	0.64	3.48	5.99	1.28
Filing Date Shares Outstanding	19.49	19.49	11.01	8.22	8.16	6.95
Total Common Shares Outstanding	19.49	14.14	10.52	8.16	8.1	6.89
Working Capital	18.65	10.04	5.93	28.32	44.49	7.54
Book Value Per Share	0.94	0.66	-0.74	3.47	5.49	1.09
Tangible Book Value	18.33	9.31	-7.75	28.32	44.49	7.54
Tangible Book Value Per Share	0.94	0.66	-0.74	3.47	5.49	1.09

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q